Investigational drug Shows Survival Benefit For Some Leukemia Patients in Phase 3 study Dr. Kamal Kant Kohli14 Jun 2022 7:00 AM ISTAn investigational drug taken while undergoing chemotherapy demonstrated superior overall survival compared to chemotherapy alone in adult patients...
Light Massage and Music to help Leukemia Related Pain and Fatigue Dr. Nandita Mohan8 Jan 2022 3:11 PM ISTCancer especially leukemia can cause severe bone or joint pain, management of pain is crucial in them. the pathology itself is known to affect both...
Light Massage and Music Therapy may help reduce Leukemia-Related Pain and Fatigue: ASCO Medical Dialogues Editorial Team30 Dec 2021 9:00 AM ISTIn a new study, researchers have found discovered light massage was more helpful and lasted longer than music therapy in managing leukemia-related...
Novartis gets CDSCO panel go ahead for Asciminib Phase 3 trial Roshni Dhar21 Nov 2021 5:18 PM ISTIn a significant development, major drug-maker Novartis has got a go ahead from the Subject Expert Committee (SEC) functional under the Central Drugs...
Health Bulletin 20/November/2021 Roshni Dhar20 Nov 2021 4:17 PM ISTHere are Top Health stories of the dayDuty of Medical Council to ensure that doctors do not indulge in offences: Madras HCHolding that it is the duty...
Novartis gets CDSCO panel nod to conduct phase 3 study of anti-cancer drug Asciminib Medical Dialogues Team18 Nov 2021 4:25 PM ISTNew Delhi: In a significant development, major drug-maker Novartis has got a go ahead from the Subject Expert Committee (SEC) functional under the...
Zydus Cadila secures USFDA okay for Nelarabine Injection in US Ruchika Sharma18 Nov 2021 12:31 PM ISTAhmedabad: Drugmaker, Zydus Cadila, today announced that the company has received final approval from the United States Food and Drug Administration...
Chronic lymphocytic leukemia- A treatable cancer Dr Meet Kumar21 Oct 2021 2:26 PM ISTChronic lymphocytic leukemia (CLL) is a type of cancerof the blood and bone marrow in which the bone marrow makes more lymphocytes than required....
Patients of Myeloproliferative neoplasms are at high risk of infection: Study MD Editorial Team20 Oct 2021 9:00 AM ISTHematologic malignancies accounted for 9% of all newly diagnosed cancers in the United States. Infections are a common complication in patients with...
Ibrutinib effective treatment for difficult to treat forms of hairy cell leukemia: Study Dr. Kamal Kant Kohli29 July 2021 9:00 AM ISTCOLUMBUS, Ohio - The oral targeted therapy drug ibrutinib is an effective treatment option for high-risk hairy cell leukemia, according to a new study...
Bristol Myers Squibb Onureg gets USFDA approval to treat Acute Myeloid Leukemia Medical Dialogues Bureau12 Sept 2020 9:15 AM ISTPrinceton: Bristol Myers Squibb recently announced that the U.S. Food and Drug Administration (FDA) has approved Onureg (azacitidine 300 mg tablets,...
Leukemia drug may help treat aggressive pediatric brain cancer, finds study Hina Zahid22 July 2020 6:15 PM ISTAgencia FAPESP - Researchers affiliated with the University of Sao Paulo's Ribeirao Preto Medical School (FMRP-USP) in Brazil have demonstrated the...
